Abstract
A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Guselkumab at 52 weeks for the Treatment of Psoriatic Arthritis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have